US 11672871
Peptide oligonucleotide conjugates
granted A61KA61K38/00A61K47/18
Quick answer
US patent 11672871 (Peptide oligonucleotide conjugates) held by Sarepta Therapeutics, Inc. expires Mon Jun 08 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sarepta Therapeutics, Inc.
- Grant date
- Tue Jun 13 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 08 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61K, A61K38/00, A61K47/18, A61K47/645, A61P